Skip to main content
Get Alerts

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,139
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,799
Class I recallsReasonable probability of serious health consequences
24,349
Class II recallsTemporary or medically reversible health consequences
2,891
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/deanos-pasta-issue-allergy-alert-undeclared-lobster-pear-and-pecorino-triangoli-ravioliPublished September 24, 2026
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,349
Class I9,799
Class III2,891
Not Yet Classified1

Showing 11,721–11,740 of 21,142 recalls

FDA Recall Ongoing Historical recordClass II

Valsartan Tablets USP, 320mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-070-90

by Torrent Pharma Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Valsartan Tablets USP, 160mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-069-90

by Torrent Pharma Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Valsartan Tablets USP, 80mg, 90 tablets per bottle, Rx Only, Manufactured by: Torrent Pharmaceuticals LTD., Indrad-382 721, India. NDC: 13668-068-90

by Torrent Pharma Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 320 mg Rx Only 30 Tablets (6x5) Unit Dose NDC 50268-786-13 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 160 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-785-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 80 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-784-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Valsartan Tablets, USP 40 mg Rx Only NDC 50268-783-15 50 Tablets (5x10) Unit Dose Manufactured for: AvKARE, Inc. Pulaski, TN 38478

by AVKARE Inc.

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: Mayne Pharma, Greenville, NC 27834, NDC 68308-841-01.

by Mayne Pharma Inc

Reason
Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

Doxycycline Hyclate USP Tablets, 100 mg packaged in a) 2-count bottles, NDC 55289-866-02; b) 6-count bottles, NDC 55289-866-06; c) 7-count bottles, NDC 55289-866-07; d) 10-count bottles, NDC 55289-866-10; e) 14-count bottles, NDC 55289-866-14; f) 20-count bottles, NDC 55289-866-20; g) 28-count bottles, NDC 55289-866-28; h) 30-count bottles, NDC 55289-866-30; i) 120-count bottles, NDC 55289-866-98; j) 300-count bottles, NDC 55289-866-87; k) 400-count bottles, NDC 55289-866-74; Rx only, Packaged By PD-Rx Pharmaceuticals, Oklahoma City, OK 73127.

by PD-Rx Pharmaceuticals, Inc.

Reason
Failed Dissolution Specifications: manufacturer West-Ward Pharm Corp. recalled these repackaged lots due to failed dissolution results.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

Ochoa's Queseria LLC

Product
Mexican Style Ricotta Cheese labeled, "Don Froylan Requeson*…
Reason
Don Froylan Requeson is being recalled because the ingredient statement does not declare milk, a major food allergen. The pasteurized whey comes from whole milk.
Published
September 5, 2018
Distribution
Firm distributes to wholesale accounts,…

View recall →

FDA Recall United States Terminated Historical recordClass II

Hostess Brands, LLC

Product
Hostess Brownies Cookies 'n Cr¿me packaged in the following…
Reason
The product ingredients statement declares egg ingredients, but the "Contains" statement fails to declare egg.
Published
September 5, 2018
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass I

Marsee Foods Inc

Product
Oatmeal Raisin Cookies, brand Cafe YUMM! Product is package…
Reason
Oatmeal Raisin Cookies are recalled because cookies may contain undeclared peanuts.
Published
September 5, 2018
Distribution
Distributed in Oregon and Washington

View recall →

FDA Recall United States Terminated Historical recordClass I

Marsee Foods Inc

Product
Ginger Spice Cookies, brand Cafe YUMM! Product is packaged…
Reason
Ginger Spice Cookies are recalled because cookies may contain undeclared peanuts.
Published
September 5, 2018
Distribution
Distributed in Oregon and Washington

View recall →

FDA Recall United States Terminated Historical recordClass I

Marsee Foods Inc

Product
Chocolate Chip Cookies, brand Cafe YUMM! Product is package…
Reason
Chocolate Chip Cookies are recalled because cookies may contain undeclared peanuts.
Published
September 5, 2018
Distribution
Distributed in Oregon and Washington

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 2 grain (120 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-158-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/4 grain (15 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-159-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1/2 grain (30 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-155-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 & 1/2 grain (90 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-157-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass I

Levothyroxine and Liothyronine (Thyroid Tablets, USP), 1 grain (60 mg), 100-count bottles, Rx Only, Manufactured for: Westminster Pharmaceuticals, LLC, 154 Downing Street, Unit 1 & 2, Olive Branch, MS 38654, NDC 69367-156-04.

by Westminster Pharmaceuticals LLC

Reason
Failed Content Uniformity Specifications: Product was manufactured using an adulterated active pharmaceutical ingredient; additionally, lack of process controls and good manufacturing practices resulted in finished product failing content uniformity specifications which can result in a product having a strength that is more or less than is labeled.
Published
August 29, 2018
Distribution
Nationwide

View recall →

FDA Recall Completed Historical recordClass II

Camber Pharmaceuticals, Inc. Valsartan Tablets, USP, 320 mg, 90 tablets, Rx Only Manufactured for: Camber Pharmaceuticals, Inc. Piscataway NJ 08854 By: Hetero Hetero Labs Limited Unit V, Pollepally Jadcherla Mahaboob Nagar - 509-301 India. NDC 31722-748-90 UPC 331722748902

by Hetero Labs Limited Unit V

Reason
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Published
August 29, 2018
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.